Abstract:Cancer prognosis prediction is typically carried out without integrating scientific knowledge available on genomic pathways, the effect of drugs on cell dynamics, or modeling mutations in the population. Recent work addresses some of these problems by formulating an uncertainty class of Boolean regulatory models for abnormal gene regulation, assigning prognosis scores to each network based on intervention outcomes, and partitioning networks in the uncertainty class into prognosis classes based on these scores. For a new patient, the probability distribution of the prognosis class was evaluated using optimal Bayesian classification, given patient data. It was assumed that (1) disease is the result of several mutations of a known healthy network and that these mutations and their probability distribution in the population are known and (2) only a single snapshot of the patient's gene activity profile is observed. It was shown that, even in ideal settings where cancer in the population and the effect of a drug are fully modeled, a single static measurement is typically not sufficient. Here, we study what measurements are sufficient to predict prognosis. In particular, we relax assumption (1) by addressing how population data may be used to estimate network probabilities, and extend assumption (2) to include static and time-series measurements of both population and patient data. Furthermore, we extend the prediction of prognosis classes to optimal Bayesian regression of prognosis metrics. Even when time-series data is preferable to infer a stochastic dynamical network, we show that static data can be superior for prognosis prediction when constrained to small samples. Furthermore, although population data is helpful, performance is not sensitive to inaccuracies in the estimated network probabilities.

A Comorbidity Knowledge-Aware Model for Disease Prognostic Prediction

A Patient-Similarity-based Model for Diagnostic Prediction

Clinical Prediction Models: Basic Concepts, Application Scenarios, and Research Strategies

Reporting and Methods in Developing Prognostic Prediction Models for Metabolic Syndrome: A Systematic Review and Critical Appraisal.

A Transfer-Learning-Based Prognosis Prediction Paradigm That Bridges Data Distribution Shift Across EMR Datasets

A Probabilistic Disease Progression Model for Predicting Future Clinical Outcome

KnowRisk: an Interpretable Knowledge-Guided Model for Disease Risk Prediction

Noninvasive Risk Prediction Models for Heart Failure Using Proportional Jaccard Indices and Comorbidity Patterns

Validation and Refinement of Two Interpretable Models for Coronavirus Disease 2019 Prognosis Prediction

Data Requirements for Model-Based Cancer Prognosis Prediction

Towards proactive palliative care in oncology: developing an explainable EHR-based machine learning model for mortality risk prediction

Semiparametric Prognosis Models in Genomic Studies.

Diagnosis Uncertain Models For Medical Risk Prediction

Comorbidity and multimorbidity prediction of major chronic diseases using machine learning and network analytics

Risk Prediction with Imperfect Survival Outcome Information from Electronic Health Records

A New Online Fuzzy Modelling Method Considering Prior Information with Its Application in PHM

Prediction of Disease Comorbidity Using HeteSim Scores based on Multiple Heterogeneous Networks.

Machine learning applications in preventive healthcare: A systematic literature review on predictive analytics of disease comorbidity from multiple perspectives

Interpretable Disease Progression Prediction Based on Reinforcement Reasoning over a Knowledge Graph

Directed Disease Networks to Facilitate Multiple-Disease Risk Assessment Modeling

A Conditional Probabilistic Model for Joint Analysis of Symptoms, Diseases, and Herbs in Traditional Chinese Medicine Patient Records